Frequent Links
Economy - Top JournalsRotator cuff Protein expression ProfilingepigeneticsSkin allergies innovationstextilescience innovationshyperammonemia neonatal disease scholarly peer review journalwildlifescience best journalsOrthodontics journalschemical-pharmaceutical analysis online journalsInternational Computational Biology JournalsEndometriosis journalsFungal Medicines journalsTropical diseases Bioengineering
BSPP (drug)
| File:BSPP structure.png | |
| Systematic (IUPAC) name | |
|---|---|
| 2,6-di-tert-butyl-4-(3-hydroxy-2-spiropentylpropyl)-phenol | |
| Clinical data | |
| Identifiers | |
| None | |
| PubChem | CID 16079861 |
| ChemSpider | 17238838 7px |
| Chemical data | |
| Formula | C21H34O2 |
| 318.492 g/mol | |
| |
| 14px (what is this?) (verify) | |
BSPP is a compound used in scientific research which acts as a positive allosteric modulator at the GABAB receptor.[1] It has a synergistic effect with GABAB agonists such as baclofen at GABAB autoreceptors but not heteroreceptors, suggesting it may be useful for distinguishing between these GABAB receptor subtypes.[2]
References
- ^ Kerr DIB, Khalafy J, Ong J, Perkins MV, Prager RH, Puspawati NM, Rimaz M. Synthesis and Biological Activity of Allosteric Modulators of GABAB Receptors, Part 2. 3-(2,6-Bis-tert-butyl-4-hydroxyphenyl)propanols. Australian Journal of Chemistry. 2006;59:457-462.
- ^ Parker DA, Marino V, Ong J, Puspawati NM, Prager RH. The CGP7930 analogue 2,6-di-tert-butyl-4-(3-hydroxy-2-spiropentylpropyl)-phenol (BSPP) potentiates baclofen action at GABA(B) autoreceptors. Clinical and Experimental Pharmacology and Physiology. 2008 Sep;35(9):1113-5. PMID 18430050
Lua error in package.lua at line 80: module 'Module:Buffer' not found.